
    
      Patients are randomized to receive the same total dosage of 3TC either twice a day (Group 1)
      or once a day (Group 2) in combination with ZDV and EFV over 48 weeks. Viral load
      measurements will be performed at Weeks 4, 8, 12, 16, 20, 24, and every 8 weeks thereafter.
    
  